Dow Jones

39 118,86

-0,12%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Oncology Pharma Inc (CE) (ONPH)
Oncology Pharma Inc (CE) (ONPH) Actualités

ONPH

Oncology Pharma (CE) (ONPH)

Oncology Pharma Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:ONPH

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
12/07/2022	14h36	InvestorsHub NewsWire	Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System	USOTC:ONPH	Oncology Pharma Inc (CE)
29/06/2022	15h23	InvestorsHub NewsWire	Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System	USOTC:ONPH	Oncology Pharma Inc (CE)
08/06/2022	14h17	InvestorsHub NewsWire	Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development	USOTC:ONPH	Oncology Pharma Inc (CE)
09/05/2022	14h48	InvestorsHub NewsWire	Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development	USOTC:ONPH	Oncology Pharma Inc (CE)
13/04/2022	14h45	InvestorsHub NewsWire	Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer	USOTC:ONPH	Oncology Pharma Inc (CE)
02/03/2022	14h03	InvestorsHub NewsWire	Oncology Pharma Reports on Progress with Ribera Solutions	USOTC:ONPH	Oncology Pharma Inc (CE)
23/02/2022	14h00	InvestorsHub NewsWire	Oncology Pharma Releases Further Feasibility Studies, Data and Capacities	USOTC:ONPH	Oncology Pharma Inc (CE)
17/02/2022	14h16	InvestorsHub NewsWire	Oncology Pharma Expands on Feasibility Studies and Data	USOTC:ONPH	Oncology Pharma Inc (CE)
14/02/2022	14h11	InvestorsHub NewsWire	Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine	USOTC:ONPH	Oncology Pharma Inc (CE)
08/02/2022	14h30	InvestorsHub NewsWire	Oncology Pharma Gives Update on Technology, Formulation and Data Creation	USOTC:ONPH	Oncology Pharma Inc (CE)
10/01/2022	14h15	InvestorsHub NewsWire	Oncology Pharma's New Year Update	USOTC:ONPH	Oncology Pharma Inc (CE)
17/12/2021	14h11	InvestorsHub NewsWire	Oncology Pharma Meeting Towards Future Developments	USOTC:ONPH	Oncology Pharma Inc (CE)
09/12/2021	14h04	InvestorsHub NewsWire	Oncology Pharma Year End Review and Outlook	USOTC:ONPH	Oncology Pharma Inc (CE)
30/11/2021	14h02	InvestorsHub NewsWire	Oncology Pharma Research and Vision	USOTC:ONPH	Oncology Pharma Inc (CE)
08/11/2021	14h00	InvestorsHub NewsWire	Oncology Pharma Reveals Plans for Development of Lead Cancer Drug Candidate	USOTC:ONPH	Oncology Pharma Inc (CE)
28/10/2021	17h11	InvestorsHub NewsWire	Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress	USOTC:ONPH	Oncology Pharma Inc (CE)
16/10/2021	02h12	StockInvest.us	High volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95	USOTC:ONPH	Oncology Pharma Inc (CE)
15/10/2021	16h51	InvestorsHub NewsWire	Oncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior Listing	USOTC:ONPH	Oncology Pharma Inc (CE)
12/10/2021	14h30	InvestorsHub NewsWire	Oncology Pharma, Inc. Update on PCAOB Audit Selection Process and License Agreement	USOTC:ONPH	Oncology Pharma Inc (CE)
05/10/2021	02h09	StockInvest.us	Big movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and low	USOTC:ONPH	Oncology Pharma Inc (CE)
17/09/2021	02h08	StockInvest.us	High volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $11.35	USOTC:ONPH	Oncology Pharma Inc (CE)
13/09/2021	14h30	InvestorsHub NewsWire	Oncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug Product	USOTC:ONPH	Oncology Pharma Inc (CE)
27/08/2021	02h08	StockInvest.us	High volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $20.38	USOTC:ONPH	Oncology Pharma Inc (CE)
26/08/2021	02h12	StockInvest.us	Volatile ride for Oncology Pharma Inc. stock price on Wednesday moving between $14.02 and $17.99	USOTC:ONPH	Oncology Pharma Inc (CE)
25/08/2021	02h09	StockInvest.us	Big movements in Oncology Pharma Inc. stock price on Tuesday moving 10.33% between high and low	USOTC:ONPH	Oncology Pharma Inc (CE)
24/08/2021	02h10	StockInvest.us	High volatility in Oncology Pharma Inc. stock price on Monday which ended trading at $15.00	USOTC:ONPH	Oncology Pharma Inc (CE)
23/08/2021	14h30	InvestorsHub NewsWire	Oncology Pharma's Co-Development Agreement Pursues Strategic and Direct Objectives	USOTC:ONPH	Oncology Pharma Inc (CE)
21/08/2021	02h10	StockInvest.us	High volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $15.42	USOTC:ONPH	Oncology Pharma Inc (CE)
19/08/2021	14h00	InvestorsHub NewsWire	Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc.	USOTC:ONPH	Oncology Pharma Inc (CE)
13/08/2021	02h11	StockInvest.us	Red day on Thursday for Oncology Pharma Inc.	USOTC:ONPH	Oncology Pharma Inc (CE)